cgoncology.comHealthcareFounded: 2010Funding to Date: $202.87MM
CG Oncology is a developer of genitally engineered oncolytic immunotherapy treatments for individuals with advanced cancer.
For more details on financing and valuation for CG Oncology, register or login.
View Enterprise Value for CG Oncology.
To read this article and more news on CG Oncology, register or login.